Libros importados hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (in English)
Type
Physical Book
Language
Inglés
Pages
62
Format
Paperback
Dimensions
25.4 x 17.8 x 0.3 cm
Weight
0.12 kg.
ISBN13
9781727529838

Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (in English)

The Law Library (Author) · Createspace Independent Publishing Platform · Paperback

Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (in English) - The Law Library

Physical Book

$ 15.92

$ 19.90

You save: $ 3.98

20% discount
  • Condition: New
It will be shipped from our warehouse between Friday, July 05 and Monday, July 08.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (in English)"

Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulation concerning charging patients for investigational new drugs. This final rule revises the charging regulation to clarify the circumstances in which charging for an investigational drug in a clinical trial is appropriate, to set forth criteria for charging for an investigational drug for the different types of expanded access for treatment use described in the agency's final rule on expanded access for treatment use of investigational drugs published elsewhere in this issue of the Federal Register, and to clarify what costs can be recovered for an investigational drug. This final rule will permit charging for a broader range of uses than was explicitly permitted previously. This book contains: - The complete text of the Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews